Drug Database
Back to search

Poland· PL-100014016

Chlorprothixen Zentiva

A chlorprothixene product containing chlorprothixeni hydrochloridum, registered in Poland by Zentiva, k.s.. The same ATC class is registered in 10 of our 19 countries.

ATC N05AF03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedChlorprothixen ZentivaATCN05AF03REGISTER NO.PL-100014016PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorprothixeni hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chlorprothixene is registered in 10 of 19 countries.

Countries holding a registration under ATC N05AF03 (chlorprothixene), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search chlorprothixene products by name

Chlorprothixene · ATC N05AF03

10 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of chlorprothixene costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Chlorprothixene · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.86
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Chlorprothixeni hydrochloridum
Manufacturer
Zentiva, k.s.
Country
Poland (PL)
ATC code
N05AF03
ATC class
Chlorprothixene
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

1 priced
  • gtin
    05909990203116
    50 szt.
    PLN 22.17
  • gtin
    05909990610167

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

27 interactions on record for chlorprothixene.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chlorprothixene against other medicinesHow interaction checks work

Chlorprothixene · interactions on record

27 records

27 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Chlorprothixene in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorprothixene products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Truxal
  • Bulgaria · Хлорпротиксен 15 Зентива
  • Czechia · Chlorprothixen Léčiva
  • Germany · Chlorprothixen Holsten, Chlorprothixen Neuraxpharm
  • Denmark · Truxal
  • Estonia · Truxal
  • Finland · Truxal
  • Hungary · Truxal
  • Iceland · Truxal
  • Lithuania · Truxal
  • Latvia · Truxal
  • Netherlands · Truxal
  • Norway · Truxal
  • Sweden · Truxal
  • Slovakia · Chlorprothixen Léčiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e11cabaf-8d3c-4931-8a71-ea8abff16c0f
GET /v1/drugs/e11cabaf-8d3c-4931-8a71-ea8abff16c0f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "Rp ¦ Skasowane ¦ 2451\n30 tabl.\n05909990203116 ¦ Rp ¦ 2452\n50 tabl.\n05909990610167 ¦ Rp ¦ 61836\n30 tabl.",
  "substance": "Chlorprothixeni hydrochloridum 50 mg",
  "common_name": "Chlorprothixeni hydrochloridum",
  "pl_product_id": "100014016",
  "pozwolenie_nr": "02031",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about chlorprothixene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console